85% of Omicron hospitalisations didn't have booster vax in England: Report

More than four-fifths of Omicron patients in England's hospitals have not had their booster doses, official figures have revealed.

Covid, coronavirus, Britain
People wearing face masks, amid the spread of the coronavirus disease, walk into the main entrance of the Royal London Hospital, in London (Photo: Reuters)
IANS London
1 min read Last Updated : Jan 01 2022 | 4:37 PM IST

More than four-fifths of Omicron patients in England's hospitals have not had their booster doses, official figures have revealed.

The UK Health Security Agency (UKHSA) confirmed the toll in its weekly surveillance update, saying 608 out of 815 hospitalised patients struck down with the ultra-infectious variant were not triple-jabbed. A quarter was unvaccinated, reports DailyMail.

Meanwhile, the health officials unveiled further data showing that booster vaccines cut the risk of hospitalisation with Omicron by up to 88 per cent.

And two doses still slashed the odds by up to 72 per cent, up to nearly six months after the jab, the report said.

Health Secretary Sajid Javid said the recent figures 'reinforced' the importance of vaccines in saving lives and preventing serious illness.

Ministers ramped up the booster drive with the aim of hitting 1 million jabs a day in an effort to give every eligible Briton the third jab before the end of the year and stop the NHS from being overwhelmed this Winter.

The UK's Prime Minister Boris Johnson bragged about hitting that target despite figures showing 9.5 million eligible adults in England are still yet to have the booster jab.

--IANS

vc/dpb

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusBritainCoronavirus Vaccine

First Published: Jan 01 2022 | 4:37 PM IST

Next Story